The Avidity and MorphoSys acquisitions have come in for criticism of late but in the wider scheme of things, they look like pretty decent business by the Swiss major.
The Avidity and MorphoSys acquisitions have come in for criticism of late but in the wider scheme of things, they look like pretty decent business by the Swiss major.